Skip to main content
Caplight Logo









Biophytis SA

Biophytis SA

Public

Biophytis SA is now publicly traded

The data on this page reflects Biophytis SA's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

Seed Round

Sep 15, 2026

Total Funding Raised

$4.18M

Company Overview

Biophytis SA is based in Paris. It has raised $4.18M.

Biophytis SA is a biotechnology company that develops drug candidates for the treatment of age-related diseases.

AI Layer

Application

Biophytis SA Comparables

Compare Biophytis SA with similar companies based on industry and business-model similarity.

No comparables are published for Biophytis SA. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Biophytis SA Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundSep 15, 2026
Seed RoundMar 13, 2026
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Stanislas Veillet

President and CEO

Executive Team

Christophe Courtillat

CFO

Executive Team

For institutional investors. Book with your work email.

Biophytis SA Investors

Notable investors and investment history

Biophytis SA investors
InvestorRounds
Bigger CapitalSeed Round
Alumni Capital ManagementSeed Round

Biophytis SA Filings

Explore SEC and related filing metadata, where available.

Biophytis SA filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Firmographic Details

HeadquartersParis
Employee Range24
Year Founded2006
Last FundingSep 15, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?